Profile
Andreas L.
Norlin is the founder of Xkout Bioscience AB. Dr. Norlin currently holds the positions of Director at ApoGlyx AB, Director at Desupervised ApS, and Chief Scientific Officer at Ascelia Pharma AB since 2020.
Dr. Norlin completed graduate and doctorate degrees at the University of Lund.
Andreas Norlin active positions
| Companies | Position | Start |
|---|---|---|
| ASCELIA PHARMA AB | Chief Tech/Sci/R&D Officer | 01/01/2020 |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Director/Board Member | - |
Former positions of Andreas Norlin
| Companies | Position | End |
|---|---|---|
Xkout Bioscience AB | Founder | - |
Training of Andreas Norlin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Health Technology |
Ascelia Pharma AB
Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Xkout Bioscience AB |
- Stock Market
- Insiders
- Andreas Norlin
















